| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.64 | 0.01 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |